We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Macys Inc | NYSE:M | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.05% | 20.09 | 20.62 | 19.64 | 19.74 | 9,569,602 | 01:00:00 |
From May 2019 to May 2024
9:31 ET - Pharmaceutical makers better beware rejecting a deal. Starboard has its next big board change with a settlement today giving it five of 11 directors, eventually, at Perrigo (PRGO). It's Starboard's biggest bet right now with a 6.7% stake and CEO Jeff Smith is taking a seat, a sign the activist fund is particularly focused on PRGO. PRGO shareholders 15 months ago batted away a $26B bid, but shares have slumped since, essentially opening the door for Starboard. In October, Starboard settled for 3 of 9 seats at DepoMed (DEPO), which it also criticized for rejecting an approach. Macy's (M) may want to remember this too if it balks too quickly at approach from Hudson's Bay (HBC.T) that WSJ reported last week. PRGO gains 1.6% to $79.33 (david.benoit@wsj.com; @DaveCBenoit)
(END) Dow Jones Newswires
February 07, 2017 09:46 ET (14:46 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
1 Year Macys Chart |
1 Month Macys Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
